SCHEMBL3213362

SCHEMBL3213362

O=C1C=C(c2cccc(C(F)(F)F)c2)/C(=C/c2cccc(C(F)(F)F)c2)O1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CISD1 Q9NZ45 2/20 0.43
TTR P02766 1/20 0.43
PIM1 P11309 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
FBP1 P09467 1/20 0.42
PGR P06401 1/20 0.41
NOTUM Q6P988 2/20 0.39
MAPT P10636 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
HSP90AA1 P07900 1/20 0.38
PKM P14618 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
NFE2L2 Q16236 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13492149 0.94 CISD1 (0.42) CISD1TTRPIM1PIM2FBP1
SCHEMBL13492161 0.92 NFE2L2 (0.42) CISD1TTRPIM1PIM2FBP1
SCHEMBL10436065 0.81 PGR (0.50) PGRNOTUMMAPTMAOB
SCHEMBL3219680 0.76 BACE1 (0.44) PIM1PIM2FBP1NOTUM
SCHEMBL2164768 0.74 KDM4E (0.49) MAPTALDH1A1MEN1LMNAKMT2A
SCHEMBL2164776 0.74 KDM4E (0.49) MAPTALDH1A1MEN1LMNAKMT2A
SCHEMBL2164772 0.74 KDM4E (0.49) MAPTALDH1A1MEN1LMNAKMT2A
SCHEMBL13492160 0.73 MEN1 (0.45) PIM1PIM2FBP1ALDH1A1MEN1
SCHEMBL13492163 0.73 MAOB (0.44) PIM1PIM2FBP1MAPTALDH1A1
SCHEMBL30275426 0.72 KDM4E (0.61) CISD1TTRPIM1PIM2FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8586618-B2 Furanone compounds and lactam analogues thereof BIOSIGNAL LIMITED (AU) 2013-11-19 US disclosed
US-8586618-B2 Furanone compounds and lactam analogues thereof BIOSIGNAL LIMITED (AU) 2013-11-19 US disclosed
US-20100035948-A1 Furanone compounds and lactam analogues thereof UNILEVER PLC (GB) 2010-02-11 US disclosed
US-20100035948-A1 Furanone compounds and lactam analogues thereof UNILEVER PLC (GB) 2010-02-11 US disclosed
US-20100035948-A1 Furanone compounds and lactam analogues thereof UNILEVER PLC (GB) 2010-02-11 US disclosed
WO-2008040097-A1 FURANONE COMPOUNDS AND LACTAM ANALOGUES THEREOF BIOSIGNAL LIMITED (AU) 2008-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035948-A1 Furanone compounds and lactam analogues thereof FDPS, CYP2C19, MRPL21 CISD1 1248/4885TTR 4438/4885PIM1 2252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.